MedPath

Fluorouracil

HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use FLUOROURACIL INJECTION safely and effectively. See full prescribing information for FLUOROURACIL INJECTION. FLUOROURACIL injection, for intravenous use Initial U.S. Approval: 1962

Approved
Approval ID

9c42eeff-ab0c-4820-94d7-e1a3df9fda74

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 27, 2023

Manufacturers
FDA

BluePoint Laboratories

DUNS: 985523874

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluorouracil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68001-524
Application NumberANDA210123
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fluorouracil
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 27, 2023
FDA Product Classification

INGREDIENTS (3)

FLUOROURACILActive
Quantity: 50 mg in 1 mL
Code: U3P01618RT
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fluorouracil - FDA Drug Approval Details